JMJD3 Exerts Oncorepressor Activity in Acute Promyelocytic Leukemia by Promoting PU.1 Expression

被引：0
|
作者：
Wang, Meng-Xi [1 ,2 ]
Yu, Shan-He [1 ]
Xiao, Min [3 ]
Chen, Juan [1 ]
机构：
[1] Shanghai Jiao Tong Univ Sch Med, Ruijin Hosp, Shanghai Inst Hematol, Natl Res Ctr Translat Med Shanghai, Shanghai 200025, Peoples R China
[2] Xuzhou Med Univ, Xuzhou Cent Hosp, Dept Hematol, Xuzhou 221009, Peoples R China
[3] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Ji Ai Genet & IVF Inst, Shanghai 200011, Peoples R China
来源：
MOLECULAR BIOLOGY | 2023年 / 57卷 / 04期
基金：
中国国家自然科学基金;
关键词：
acute myeloid leukemia; histone demethylase; JMJD3; PU; 1; myeloid differentiation; ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; DIFFERENTIATION; MACROPHAGE;
D O I：
10.1134/S0026893323040179
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
All-trans retinoic acid (ATRA) in acute promyelocytic leukemia (APL) has been the most famous differentiation induction therapy during which the expression of PU.1, a key transcription factor (TF) for myeloid lineage determination in normal hematopoiesis is restored. In our previous studies, we found a stress-inducible H3K27 demethylase, JMJD3, to directly upregulate PU.1 expression to promote myeloid commitment during normal myelopoiesis. In addition, JMJD3 acts as an oncorepressor and plays a critical regulatory role in the initiation and progression of malignant hematopoiesis. In this study, we further resolved the relationship between JMJD3 and PU.1 in APL therein JMJD3 exerts oncorepressor activity via promoting PU.1 expression.
引用
收藏
页码：653 / 660
页数：8
相关论文
共 50 条
  • [1] JMJD3 Exerts Oncorepressor Activity in Acute Promyelocytic Leukemia by Promoting PU.1 Expression
    Meng-Xi Wang
    Shan-He Yu
    Min Xiao
    Juan Chen
    Molecular Biology, 2023, 57 : 653 - 660
  • [2] The significance of low PU.1 expression in patients with acute promyelocytic leukemia
    Zhu, Xuehua
    Zhang, Hui
    Qian, Maoxiang
    Zhao, Xujie
    Yang, Wentao
    Wang, Ping
    Zhang, Ji
    Wang, Kankan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
  • [3] Regulation of the hematopoietic cell kinase (HCK) by PML/RARα and PU.1 in acute promyelocytic leukemia
    Zou, Dandan
    Yang, Xianwen
    Tan, Yun
    Wang, Ping
    Zhu, Xuehua
    Yang, Wentao
    Jia, Xiaohong
    Zhang, Ji
    Wang, Kankan
    LEUKEMIA RESEARCH, 2012, 36 (02) : 219 - 223
  • [4] JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML
    Yu, Shan-He
    Zhu, Kang-Yong
    Chen, Juan
    Liu, Xiang-Zhen
    Xu, Peng-Fei
    Zhang, Wu
    Yan, Li
    Guo, He-Zhou
    Zhu, Jiang
    NATURE COMMUNICATIONS, 2018, 9
  • [5] PU.1 and CEBPA expression in acute myeloid leukemia
    Dalo, Francesco
    Di Ruscio, Annalisa
    Guidi, Francesco
    Fabiam, Emiliano
    Greco, Mariangela
    Rumi, Carlo
    Hohaus, Stefan
    Voso, Maria Teresa
    Leone, Giuseppe
    LEUKEMIA RESEARCH, 2008, 32 (09) : 1448 - 1453
  • [6] Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia
    Qian, Maoxiang
    Jin, Wen
    Zhu, Xuehua
    Jia, Xiaohong
    Yang, Xianwen
    Du, Yanzhi
    Wang, Kankan
    Zhang, Ji
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [7] Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia
    Yang, X-W
    Wang, P.
    Liu, J-Q
    Zhang, H.
    Xi, W-D
    Jia, X-H
    Wang, K-K
    ONCOGENE, 2014, 33 (21) : 2700 - 2708
  • [8] The histone demethylase Jmjd3 regulates zebrafish myeloid development by promoting spil expression
    Yu, Shan-He
    Zhu, Kang-Yong
    Zhang, Fan
    Wang, Juan
    Yuan, Hao
    Chen, Yi
    Jin, Yi
    Dong, Mei
    Wang, Lei
    Jia, Xiao-E
    Gao, Lei
    Dong, Zhi-Wei
    Ren, Chun-Guang
    Chen, Li-Ting
    Huang, Qiu-Hua
    Deng, Min
    Zon, Leonard I.
    Zhou, Yi
    Zhu, Jiang
    Xu, Peng-Fei
    Liu, Ting-Xi
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2018, 1861 (02): : 106 - 116
  • [9] PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia
    Wang, Kankan
    Wang, Ping
    Shi, Jiantao
    Zhu, Xuehua
    He, Miaomiao
    Jia, Xiaohong
    Yang, Xianwen
    Qiu, Fei
    Jin, Wen
    Qian, Maoxiang
    Fang, Hai
    Mi, Jianqing
    Yang, Xuzhi
    Xiao, Huasheng
    Minden, Mark
    Du, Yanzhi
    Chen, Zhu
    Zhang, Ji
    CANCER CELL, 2010, 17 (02) : 186 - 197
  • [10] Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia
    Li, Yunan
    Zhang, Mingying
    Sheng, Mengyao
    Zhang, Peng
    Chen, Zizhen
    Xing, Wen
    Bai, Jie
    Cheng, Tao
    Yang, Feng-Chun
    Zhou, Yuan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (06) : 1065 - 1077
12345